The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID ... 19 vaccine option," said Peter Marks, director of the FDA's ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday ... 1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID ... The FDA’s approval of the vaccine comes as the federal agency announced ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against serious COVID-19 impacts.

The latest flu vaccines are now available, and just like the COVID-19 shots, it's recommended to get the flu shot in ...

The Novavax vaccine, which was approved by the FDA at the end of August, is the only non-mRNA updated COVID vaccine that is ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

The FDA issued Emergency Use Authorization for the Pfizer-BioNTech vaccine on Dec. 11, 2020, and for the Moderna vaccine on Dec. 18, 2020 for those 18 and older. Novavax was approved June 7 ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...